Skip to main content

Table 2 Daily agendas for the community engagements: assisted reproductive technologies and pathology testing for vitamin B 12 and folate

From: The ASTUTE Health study protocol: Deliberative stakeholder engagements to inform implementation approaches to healthcare disinvestment

Assisted reproductive technologies:
Day 1
Objectives: Specific Activities:
Share knowledge regarding health policy in Australia, assisted reproductive technologies and frameworks for decision-making. Welcome, introductions and orientation (large group)
Explore preliminary responses and construct funding criteria. Presentations and questions: health policy in Australia, ART safety and effectiveness (large group); costs; ethical frameworks (100 minutes; large group)
  Activity and discussion: International comparisons to identify perceived strengths and weaknesses of different funding models (40 minutes; large group)
  Activity and deliberation: Construct exhaustive list of possible criteria that could be used to restrict funding for ART (large group); refine this list (small groups) and vote on top 5 criteria that should and should not be considered for imposing funding restrictions (individuals) (total 90 minutes)
  Discussion: other information required to construct funding scenarios (30 minutes; large group)
Day 2
Objectives: Specific Activities:
To determine if the criteria for the public funding of ART should be changed; why; and how Presentation and questions: information requested after day 1 (15 minutes; large group)
  Presentation and questions: summary of findings from other stakeholders (15 minutes; large group)
  Activity: Construction of funding scenario (45mins; individual/pairs)
  Activity and deliberation: Consensus building on funding scenarios (75 minutes; large group)
  Debrief and close
Pathology testing for vitamin B 12 and folate:
Day 1
Objectives: Specific Activities:
To determine what considerations should be taken into account when making decisions about how B12/folate pathology tests are publicly subsidised Discussion: experience and expectations as healthcare consumers (50 minutes; large group)
  Presentation and questions: pathology in General Practice; defining the policy context (75 minutes; large group)
  Discussion: Responding to utilization changes (45 mins; large group)
  Activity and participant questions: General testing epidemiology (60 minutes; large group)
Day 2
Objectives: Specific Activities:
To determine what considerations should be taken into account when making decisions about how B12/folate pathology tests are publicly subsidised Presentation/questions: B12/folate testing (30 minutes; large group)
  Presentation and questions: Rise in level of B12/folate testing and stakeholder responses (15 minutes; large group)
  Activity and deliberation: What things should be considered when making decisions about how much we should publicly subsidise B12/folate pathology tests? List of factors for consideration (large group); determine 5 most important factors (small group); consensus building activities (large group) (total 150 minutes)
  Debrief and close